Positive Anti-Histone Antibodies in Patients with Polymyositis
Khoirul Falah(1), Deshinta Putri Mulya(2*)
(1) Internal Medicine Specialist Program, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Sardjito Hospital
(2) Division of Allergy & Immunology, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Sardjito Hospital
(*) Corresponding Author
Abstract
Background. Polymyositis is an idiopathic inflammatory myopathy characterized by proximal symmetric muscle weakness, increased skeletal muscle enzyme levels, electromyographic abnormalities, and nonspecific muscle biopsy findings. Autoimmune mechanisms are thought to be the pathogenesis of the disease. Some autoantibodies have specificity and a high relationship with myositis.
Case. A 23-year-old male presented with progressive quadriparesis, with predominant lower limb weakness, and severe myalgia of one-month duration, significantly impairing ambulation. He has a history of occupational exposure to propylene gas and atmer liquid while working in a plastic factory. Muscle strength in upper extremities were 4 and lower extremities were 3. Laboratory examination showed CK level 11856 U/L, SGOT 773 U/L, SGPT 486 U/L, LDH 1601 U/L, ANA IF 1:1000 with speckled pattern, normal electroneuromyography, anti-Histone antibodies (++). The patient refused a muscle biopsy. The patient met 2 of the 4 criteria so he was diagnosed with possible polymyositis and was treated with methylprednisolone injection 125 mg/ 6 hours for 3 days then tappering down , mycophenolate acid 2x180 mg , mecobalamin 2x500 mcg, and vitamin D 1x400 mg. After 1 month of therapy, muscle weakness improved and he was able to walk again.
Discussion. Specific antibodies for myositis include antisynthetase, anti-Jo-1, anti-PL-7, anti-EJ, anti-PL-12, and anti-Mi-2, antibodies associated with myositis include anti-PM-Sci, anti-Ku , anti-KJ, anti-Ro/SSA.Anti-histone antibodies are commonly present in drug-induced lupus, but some studies have shown an association with other autoimmune and rheumatic diseases. Specificity pattern of serum anti-histone antibodies (AHA) on part of polymyositis patient similar with serum pattern of systemic sclerosis. Another study showed positive results in 17% of 46 polymyositis and dermatomyositis patients.
Summary. A young man with clinical and laboratory criteria fulfilling the diagnosis of possible polymyositis, positive anti-histone antibodies were obtained, which is an antibody that is rarely found in cases of polymyositis.Keywords
References
Setiyohadi, B. G. 2006. Miopati Inflamatif. In: Sudoyo AW, Setiyohadu BG, Alwi I, Simadibrata M, Setiati S, editor. Buku ajar ilmu penyakit dalam. 6th Ed. Jakarta: Pusat Penerbitan Departemen Imu Penyakit Dalam FKUI.
Dalakas, M. C. 2005. Polymyositis, dermatomyositis, and inclusion body myositis. In: Braunwald, editor. Harrison's principles of internal medicine. 16th Ed. New York: McGraw-Hill.
Hunter, K., Lyon, M. G. 2012. Evaluation and Management of Polymyositis. India J Dermatol. Sep-Okt; 57(5): 371–374. doi: 10.4103/0019-5154.100479
Yang SH, Chang C, Lian ZX. Polymyositis and dermatomyositis - challenges in diagnosis and management. J Transl Autoimmun. 2019 Oct 8;2:100018. doi:
1016/j.jtauto.2019.100018.
Peng, S. L., Craft, J. E., 2017. Anti-nuklear Antibodies. Kelley and Firestein’s Textbook of Rheumatology (10th Edition).
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–347. doi: 10.1056/NEJM197502132920706.
Ballinger, A. P. S.2003. Polymyositis & dermatomyositis. In: Ballinger APS, editor. Clinical medicine. 3rd Ed. Philadelphia: Saunders;
Papadakis, M. A., McPhee, S. J., Rabow, M. W. 2008. Curent medical diagnosis & treatment. 45th Ed. New York: McGraw-Hill;.
Ghirardello, A., Bassi, N., Palma L., Borella, E., Domeneghetti, M., Punzi, L., Doria, A. 2013. Autoantibodies in polymyositis and dermatomyositis. Current Rheumatology Reports. Curr Rheumatol Rep. Jun;15(6):335.
Nakashima R, Mimori T. Clinical and pathophysiological significance of myositisspecific and myositis-associated autoantibodies. Int. J. Clin. Rheumatol. (2010) 5(5), 523–536
Doyle, H. A., Aswad, D. W., Mamula, M. J. 2013. Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. Autoimmunity. Feb;46(1):6-13. doi:
3109/08916934.2012.710859.
Kubo, M., Ihn, H., Yazawa, N., Sato, S., Kikuchi, K., Tamaki, K. 1999. Prevalence and Antigen Specificity of Anti-Histone Antibodies in Patients with
Polymyositis/Dermatomyositis. J Invest Dermatol . 112:711-715.
Lundbrerg, E., Ingrid, V. J., Dani Lara. 2009. Polymyositis, dermatomyositis, inflamatory diseases of muscle and other myopathies. Dalam: Bijlsma JW, editor. Eular compendium on rheumatic disease. First edition. Switzerland: EULAR.
Vleugels, R. A., Callen, J. P. 2009. Dermatomyositis: Current and future therapies.
Expert Rev Dermatology. 2009; 4:581. 9.
DOI: https://doi.org/10.22146/actainterna.101290
Article Metrics
Abstract views : 195Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Acta Interna: The Journal of Internal Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Acta Interna The Journal of Internal Medicine Indexed by:
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.